174 related articles for article (PubMed ID: 38106820)
1. Mucormycosis, New Causative Agents, and New Susceptible Populations: Review of Cases in a Tertiary Care Hospital in Iran (2007-2021).
Darazam IA; Babamahmoodi A; Ebrahimi MJ; Moafi M; Dilmaghani NA; Mardani M; Shokouhi S; Gharehbagh FJ; Chalmiani EM; Shabani M; Bidari F; Jamali E; Khoshsirat S; Shahriari M; Sabeti S; Rahmani Z; Mousavinejad SA; Ebrahimzadeh K; Hallajnejad M
Iran J Public Health; 2023 Nov; 52(11):2467-2473. PubMed ID: 38106820
[TBL] [Abstract][Full Text] [Related]
2. Increased incidence of rhino-orbital mucormycosis in an educational therapeutic hospital during the COVID-19 pandemic in western Iran: An observational study.
Avatef Fazeli M; Rezaei L; Javadirad E; Iranfar K; Khosravi A; Amini Saman J; Poursabbagh P; Ghadami MR; Parandin MM; Dehghani A; Ahmadi Jouybari T; Mahdavian B; Eivazi N; Rezaei S; Rezaei A; Emami B; Haqgou M; Bozorgomid A; Sayad B
Mycoses; 2021 Nov; 64(11):1366-1377. PubMed ID: 34252988
[TBL] [Abstract][Full Text] [Related]
3. Rhino-orbital-cerebral-mucormycosis in COVID-19: A systematic review.
Bhattacharyya A; Sarma P; Sharma DJ; Das KK; Kaur H; Prajapat M; Kumar S; Bansal S; Prakash A; Avti P; Thota P; Reddy DH; Gautam BS; Medhi B
Indian J Pharmacol; 2021; 53(4):317-327. PubMed ID: 34414911
[TBL] [Abstract][Full Text] [Related]
4. Rhino-orbital-cerebral mucormycosis: An epidemiological study from a tertiary care referral center in Western India.
Patel R; Jethva J; Bhagat PR; Prajapati V; Thakkar H; Prajapati K
Indian J Ophthalmol; 2022 Apr; 70(4):1371-1375. PubMed ID: 35326057
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology and treatment of mucormycosis.
Lewis RE; Kontoyiannis DP
Future Microbiol; 2013 Sep; 8(9):1163-75. PubMed ID: 24020743
[TBL] [Abstract][Full Text] [Related]
6. Emergence of Rhino-Orbito-Cerebral Mucormycosis in Peru: Impact of the COVID-19 Pandemic.
Cumpa-Quiroz R; Elguera-Falcón F; Guevara-Lazo DR
Cureus; 2023 Sep; 15(9):e45240. PubMed ID: 37842460
[TBL] [Abstract][Full Text] [Related]
7. Rhino-orbito-cerebral mucormycosis during the COVID-19 third wave in 2021: an Egyptian preliminary report from a single tertiary hospital.
Alloush TK; Mansour O; Alloush AT; Roushdy T; Hamid E; El-Shamy M; Shokri HM
Neurol Sci; 2022 Feb; 43(2):799-809. PubMed ID: 34787754
[TBL] [Abstract][Full Text] [Related]
8. Risk Factors of COVID-19 Associated Mucormycosis (CAM) in Iranian Patients: A Single-Center Retrospective Study.
Tavakolpour S; Irani S; Yekaninejad MS; Alimardi M; Hasibi M; Abdollahi H; Kazemi MA; Lotfi M; Shahbazian H; Nazemian Yazdi NA; Samimiardestani S; Firouzifar M; Farahbakhsh F; Mirzaee Goodarzi M; Feiz F; Salehinia F
Mycopathologia; 2022 Dec; 187(5-6):469-479. PubMed ID: 36202942
[TBL] [Abstract][Full Text] [Related]
9. COVID-19-associated rhino-orbital-cerebral mucormycosis: A systematic review, meta-analysis, and meta-regression analysis.
Bhattacharyya A; Sarma P; Kaur H; Kumar S; Bhattacharyya J; Prajapat M; Prakash A; Sharma S; Reddy DH; Thota P; Bansal S; Gautam BS; Medhi B
Indian J Pharmacol; 2021; 53(6):499-510. PubMed ID: 34975140
[TBL] [Abstract][Full Text] [Related]
10. Fatality Chooses Its Path Through the Orbit: A Study of Rhino-Orbito-Cerebral Mucormycosis as a Complication of COVID-19 Infection.
Mehfooz S; Mehrotra N; Usmani T; Raj V
Cureus; 2022 Nov; 14(11):e31822. PubMed ID: 36579288
[TBL] [Abstract][Full Text] [Related]
11. Rhino-orbito-cerebral mucormycosis and its resurgence during COVID-19 pandemic: A review.
Karkhur S; Soni D; Chauhan K; Sarkar D; Gautam M; Verma S; Nyodu R; Yadav N; Sharma B
Indian J Ophthalmol; 2023 Jan; 71(1):39-56. PubMed ID: 36588206
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 Associated Rhino-Orbital-Cerebral Mucormycosis: Clinical Features, Antifungal Susceptibility, Management and Outcome in a Tertiary Hospital in Iran.
Abdorahimi M; Pakdel F; Salehi M; Alcazar-Fuoli L; Hashemi SJ; Daie Ghazvini R; Ahmadkhani F; Ahmadikia K; Abdollahi A; Debran JCS; Tabari A; Farrokh F; Mousavand A; Afarinesh Khaki P; Salami Khaneshan A; Ibrahim AS; Khodavaisy S
Mycopathologia; 2023 Oct; 188(5):783-792. PubMed ID: 37672164
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 and Mucormycosis: A Black Fungus Disaster?
Chillana S; Mohit Chilana KA
Indian J Dermatol; 2022; 67(5):535-538. PubMed ID: 36865825
[TBL] [Abstract][Full Text] [Related]
14. Association of Serum Iron Studies in COVID Associated Mucormycosis with Stage of the Disease.
Rao C; R M
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443509
[TBL] [Abstract][Full Text] [Related]
15. First report of COVID-19-associated rhino-orbito-cerebral mucormycosis in pediatric patients with type 1 diabetes mellitus.
Diwakar J; Samaddar A; Konar SK; Bhat MD; Manuel E; Hb V; Bn N; Parveen A; Hajira SN; Srinivas D; S N
J Mycol Med; 2021 Dec; 31(4):101203. PubMed ID: 34517273
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1.
Sen M; Honavar SG; Bansal R; Sengupta S; Rao R; Kim U; Sharma M; Sachdev M; Grover AK; Surve A; Budharapu A; Ramadhin AK; Tripathi AK; Gupta A; Bhargava A; Sahu A; Khairnar A; Kochar A; Madhavani A; Shrivastava AK; Desai AK; Paul A; Ayyar A; Bhatnagar A; Singhal A; Nikose AS; Bhargava A; Tenagi AL; Kamble A; Nariani A; Patel B; Kashyap B; Dhawan B; Vohra B; Mandke C; Thrishulamurthy C; Sambare C; Sarkar D; Mankad DS; Maheshwari D; Lalwani D; Kanani D; Patel D; Manjandavida FP; Godhani F; Agarwal GA; Ravulaparthi G; Shilpa GV; Deshpande G; Thakkar H; Shah H; Ojha HR; Jani H; Gontia J; Mishrikotkar JP; Likhari K; Prajapati K; Porwal K; Koka K; Dharawat KS; Ramamurthy LB; Bhattacharyya M; Saini M; Christy MC; Das M; Hada M; Panchal M; Pandharpurkar M; Ali MO; Porwal M; Gangashetappa N; Mehrotra N; Bijlani N; Gajendragadkar N; Nagarkar NM; Modi P; Rewri P; Sao P; Patil PS; Giri P; Kapadia P; Yadav P; Bhagat P; Parekh R; Dyaberi R; Chauhan RS; Kaur R; Duvesh RK; Murthy R; Dandu RV; Kathiara R; Beri R; Pandit R; Rani RH; Gupta R; Pherwani R; Sapkal R; Mehta R; Tadepalli S; Fatima S; Karmarkar S; Patil SS; Shah S; Shah S; Shah S; Dubey S; Gandhi S; Kanakpur S; Mohan S; Bhomaj S; Kerkar S; Jariwala S; Sahu S; Tara S; Maru SK; Jhavar S; Sharma S; Gupta S; Kumari S; Das S; Menon S; Burkule S; Nisar SP; Kaliaperumal S; Rao S; Pakrasi S; Rathod S; Biradar SG; Kumar S; Dutt S; Bansal S; Ravani SA; Lohiya S; Ali Rizvi SW; Gokhale T; Lahane TP; Vukkadala T; Grover T; Bhesaniya T; Chawla U; Singh U; Une VL; Nandedkar V; Subramaniam V; Eswaran V; Chaudhry VN; Rangarajan V; Dehane V; Sahasrabudhe VM; Sowjanya Y; Tupkary Y; Phadke Y;
Indian J Ophthalmol; 2021 Jul; 69(7):1670-1692. PubMed ID: 34156034
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 associated rhino-orbito-cerebral mucormycosis, risk factors and outcome predictors; a multicentric study.
Rajabi MT; Aghajani A; Rafizadeh SM; Jamshidian Tehrani M; Poursayed Lazarjani SZ; Keshmirshekan MM; Mohammadi A; Akrami A; Parandin MM; Rajabi MB; Hosseini SS; Akbari M
Int Ophthalmol; 2023 Apr; 43(4):1375-1386. PubMed ID: 36209307
[TBL] [Abstract][Full Text] [Related]
18. Rhino orbital cerebral mucormycosis in settings of COVID-19 infection: A case series of thirteen patients.
Verma R; Chakraborty R; Keerthiraj DB; Pal US
Natl J Maxillofac Surg; 2023; 14(2):311-316. PubMed ID: 37661985
[TBL] [Abstract][Full Text] [Related]
19. COVID-19-Associated Mucormycosis: An Opportunistic Fungal Infection. A Case Series and Review.
Balushi AA; Ajmi AA; Sinani QA; Menon V; Berieki ZA; Shezawi AA; Azri SA; Rashdi AA; Jardani AA; Baluki TA; Ghaithi SA; Reesi AA; Al-Za'abi AT; Al' Balushi MA; Maqbali TA
Int J Infect Dis; 2022 Aug; 121():203-210. PubMed ID: 35533833
[TBL] [Abstract][Full Text] [Related]
20. Clinical Profile of Central Nervous System Involvement in Patients with Rhino Orbital Cerebral Mucormycosis.
Yadav S; Bs N; Ak S
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
